119th Congress · introduced in the House · Jul 15, 2025
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Official title from Congress.gov
Latest action (Jul 15, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
15 citations.
THE METROHEALTH SYSTEM · lobbying firm or registrant: THE METROHEALTH SYSTEM
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$230,000
Spent on own lobbying
…alth system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
…nts and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
…s concerning 340B program rebate proposal. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma ca…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$40,000
Paid to lobbying firm
…nts and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$40,000
Paid to lobbying firm
…Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma ca…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: THE METROHEALTH SYSTEM
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$210,000
Spent on own lobbying
…alth system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025; H.R. 7279/S. 3707, Nurse Faculty Shortage Reduction Act of 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
…nts and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Health Issues
$50,000
Paid to lobbying firm
…Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma ca…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: THE METROHEALTH SYSTEM
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$190,000
Spent on own lobbying
…alth system costs; Pandemic and All Hazards Preparedness Act reauthorization; H.R. 267, the Health care PRICE Transparency Act; H.R. 5256, the 340B ACCESS Act; H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medicare/Medicaid
$40,000
Paid to lobbying firm
…nts and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$40,000
Paid to lobbying firm
…Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: THE METROHEALTH SYSTEM
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · amended · posted Jan 20, 2026 · issue area: Health Issues
$230,000
Spent on own lobbying
…rs Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: THE METROHEALTH SYSTEM
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 21, 2025 · issue area: Health Issues
$150,000
Spent on own lobbying
…rs Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
…nts and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE METROHEALTH SYSTEM · lobbying firm or registrant: ALSTON & BIRD LLP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Health Issues
$50,000
Paid to lobbying firm
…Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing